| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9377669 | Biological Psychiatry | 2005 | 9 Pages |
Abstract
These 1-year open trial data found VNS to be well tolerated, suggesting a potential long-term, growing benefit in treatment-resistant depression, albeit in the context of changes in depression treatments. Comparative long-term data are needed to determine whether these benefits can be attributed to VNS.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
A. John Rush, Harold A. Sackeim, Lauren B. Marangell, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Phil Lavori, Robert Howland, Mitchel A. Kling, Barry Rittberg, Linda Carpenter, Philip Ninan, Francisco Moreno, Thomas Schwartz, Charles Conway,